로딩 중…
지수 로딩 중…
Kodiak Sciences Inc.
KOD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$39.83-4.21%
2026-08-03
Financials
Valuation Metrics
Kodiak Sciences Inc.'s Market Cap is $2.49B. At end of 2025 it was $1.49B. Ranked #1861 of 3,111 in US market (top 60%), #682 of 1,445 on NASDAQ (top 47%), #109 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 41%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.49B | US#1,861/3,111 Sec#109/269 |
| Revenue | $0.00 | US#2,980/3,111 Sec#205/269 |
| Net Income | $-231M | US—/3,111 Sec—/269 |
| Total Assets | $306M | US#2,899/3,111 Sec#209/269 |
| Net Assets | $112M | US#2,871/3,111 Sec#224/269 |
| Value | ||
| P/B | 22.23x | US#2,849/3,111 Sec#240/269 |
| FCF Yield | -5.94% | US—/3,111 Sec—/269 |
| Profitability | ||
| ROA | -75.38% | US#3,038/3,111 Sec#255/269 |
| Financial Health | ||
| Debt Ratio | 172.97% | US#1,656/3,111 Sec#196/269 |
| Total Debt | $156M | US#2,296/3,111 Sec#104/269 |
| FCF | $-148M | US#2,687/3,111 Sec#189/269 |
| Cash | $170M | US#1,852/3,111 Sec#133/269 |
| Current Ratio | 3.54x | US#659/3,111 Sec#181/269 |
| Performance | ||
| 1Y Return | 498.95% | US#11/3,111 Sec#5/269 |
| 1M Return | 3.35% | US#393/3,111 Sec#24/269 |
| From 52W High | -16.74% | US#1,218/3,111 Sec#82/269 |
| 1Y MDD | -36.24% | US#1,757/3,111 Sec#123/269 |
| Trading | ||
| Volume | 556,979 shares | US#2,170/3,111 Sec#217/269 |
| Trading Value | $22M | US#2,015/3,111 Sec#151/269 |
| Per Share | ||
| EPS | $-4.32 | US—/3,111 Sec—/269 |
| BPS | $2.96 | US#2,426/3,111 Sec#160/269 |